NCT02107235View on ClinicalTrials.gov

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Interventions
DRUG

oral rigosertib

DRUG

cisplatin

RADIATION

Radiotherapy

Trial Locations (4)

10467

Montefiore Medical Center, The Bronx

19713

Christiana Care Health Services, Newark

43210

The Ohio State University Comprehensive Cancer Center, Columbus

80045

University of Colorado Cancer Center, Aurora

All Listed Sponsors
lead

Traws Pharma, Inc.

INDUSTRY

NCT02107235 - Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer | Biotech Hunter | Biotech Hunter